Clinical trials solutions provider WCG is acquiring tech company The Contract Network to improve alignment and ...

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, today announced it has selected ...

Epitopea has confirmed the Institute of Cancer Research Professor in Women’s Cancers, Susana Banerjee, as chief investigator ...

Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

Psychedelics — once largely confined to the fringes of medicine and culture — are now drawing attention at the highest levels ...

H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $74 billion of capital under management, is ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Celerion, a global leader in clinical pharmacology and bioanalytical sciences, today announced a majority investment from THL ...

Tortugas Neuroscience ("Tortugas"), a neurology-focused biotech company developing novel medicines with derisked mechanisms of actions, for large and well-defined indications, tod ...

Target identification is a critical and challenging step in drug discovery, with only a small fraction of human genes ...

Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

As demand from sponsors and CROs for proven, large‑scale remote patient monitoring (RPM) capabilities continues to ...